|   | |
| Names | |
|---|---|
| Preferred IUPAC name N,N-Diethyl-N-methyl-3-[(methylcarbamoyl)oxy]anilinium iodide | |
| Other names AR-16, TL-1217 | |
| Identifiers | |
| 3D model (JSmol) | |
| ChemSpider | |
|  PubChem CID | |
|  CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C13H21IN2O2 | |
| Molar mass | 364.227 g·mol−1 | 
| Related compounds | |
| Related compounds | Neostigmine Miotine | 
| Hazards | |
| Lethal dose or concentration (LD, LC): | |
| LD50 (median dose) | 129 μg/kg (Subcutaneous, mice) [1] 75 μg/kg (Subcutaneous, cats) [1] 75 μg/kg (Subcutaneous, dogs) [1] 150 μg/kg (Subcutaneous, rabbits) [1] 122.5 μg/kg (Intramuscular, rats) [2] | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
T-1123 is a carbamate-based acetylcholinesterase inhibitor. It was investigated as a chemical warfare agent starting in 1940. It does not go through the blood-brain barrier due to the charge on quaternary nitrogen. The antidote is atropine. [3] T-1123 is a quaternary ammonium ion. A phenyl carbamate ester is bonded in the meta position to the nitrogen on a diethylmethyl amine. The chloride and methylsulfate salt of T-1123 is TL-1299 and TL-1317, respectively.
T-1123 can be produced from m-diethylaminophenol, methyl isocyanate and methyl iodide. First, m-diethylaminophenol is reacted with methyl isocyanate to produce a methylcarbamate. The resulting methylcarbamate is then reacted with methyl iodide to produce T-1123. [1]